Since its founding in 1947 by Sidney Farber, MD, Dana-Farber Cancer Institute has been committed to offering cancer patients the best treatment available today, while developing tomorrow’s cures through research. At the same time, Dana-Farber trains new generations of physicians and scientists to advance the understanding and prevention of cancer and related diseases.
- A pioneer in the development of cancer treatments used around the world.
- A principal teaching affiliate of Harvard Medical School.
- A founding member of the Dana-Farber/Harvard Cancer Center(DF/HCC), which is one of 41 NCI-designated Comprehensive Cancer Centers in the United States.
- A founding member of the Center for AIDS Research at Harvard University and one of 21 federally designated Centers for AIDS Research.
- Accredited with Magnet status from the American Nurses Credentialing Center — an honor held by just 6 percent of hospitals in the United States.
- A collaborator with Brigham and Women’s Hospital in adult cancer care (Dana-Farber/Brigham and Women’s Cancer Center), and with Boston Children’s Hospital in pediatric cancer care (Dana-Farber/Children’s Hospital Cancer Center).
- One of the top recipients, among independent hospitals, of grant funding from the National Cancer Institute and National Institutes of Health.
- A provider of innovative therapies and hope to patients from across the country and around the world.